Balyasny Asset Management L.P.
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1218710
Chicago, IL
Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,497,432
-$909,048 QoQ
Shares Held
88,240
-59.5% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#84
of 279 holders
Holding Since
Mar 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Derivatives in AUPH
reported options exposure · as of Sep 30, 2022CallValue
$977,600
CallShares
130,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. AUPH ranks #114 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in AUPH
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,497,432 | 88,240 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $2,406,480 | 217,781 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $892,303 | 110,983 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $426,657 | 47,512 | Shares | Sole | 2025-02-14 | |
| 2024-03-31 | $1,447,263 | 288,875 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $7,974,255 | 887,014 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,042,173 | 262,828 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,797,569 | 805,534 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,383,323 | 1,312,347 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,986,469 | 459,831 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $977,600 | 130,000 | Call | Sole | 2022-11-15 | |
| 2022-09-30 | $6,420,478 | 853,787 | Shares | Other | 2022-11-15 | |
| 2022-06-30 | $5,017,472 | 499,251 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $6,717,412 | 542,602 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||